Tempo Pharmaceuticals, Inc.

Scientific Advisory Board

Bruce Zetter, Ph.D.
Chairman. Professor Harvard Medical School and Chief Scientific Officer, Children’s Hospital, Boston.

Roger Cohen, M.D.
Director Phase I Clinical Program, Fox Chase Cancer Center.

Lee Ellis, M.D.
Professor Surgical Oncology, MD Anderson.

Robert Langer, Ph.D.
Institute Professor, Massachusetts Institute of Technology.

Ram Sasisekharan, Ph.D.
Founder Tempo Pharmaceuticals and Professor, Massachusetts Institute of Technology.

Shiladitya Sengupta, Ph.D.
Founder Tempo Pharmaceuticals and Assistant Professor, Harvard Medical School.

Robert Tepper, M.D.
Former President R&D, Millennium Pharmaceuticals.

Daniel Von Hoff, M.D.
Director Clinical Translation, Arizona Health Center.

Tempo’s Core Values include a passionate commitment to improving the lives of patients and building an outstanding company; scientific excellence and innovation focused on important products and absolute integrity in everything we do.
 
 
Privacy Policy | Terms & Conditions of Use
Tempo Pharmaceuticals, Inc. 161 First Street Cambridge, MA 02142     p 617 551 9600   f 617 494 1544
Copyright 2007 © Tempo Pharmaceuticals, Inc. All rights reserved.